Results 81 to 90 of about 1,537,923 (347)

Three-Dimensional Transthoracic Echocardiograpic Assessment of Pseudoaneurysm of Mitral Aortic Intervalvular Fibrosa: The Benefit of the Added Dimension

Heart India, 2015
We report a case of 25-year-old female presenting to our department for evaluation of dyspnea on exertion. Two-dimensional transthoracic echocardiography showed a sac-like aneurysmal structure arising from the left ventricular outflow tract region ...
Varun Shankar Narain, Rajiv Bharat Kharwar, Rishi Sethi, Akshyaya Pradhan   +3 more
doaj   +1 more source

Prevalence of transthyretin cardiac amyloidosis in undifferentiated heart failure with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 1176-1182, April 2025.
Abstract Aims Transthyretin amyloid cardiomyopathy (ATTR‐CM) is an increasinglyrecognized cause of heart failure with preserved ejection fraction (HFpEF), which may be diagnosed non‐invasively using 99mTc 3,3‐diphosphono‐1,2‐propanodicarboxylic acid (DPD) scintigraphy‐based diagnostic criteria.
L. Healy, G. Giblin, A. Gray, N. Starr, L. Murphy, D. O'Sullivan, E. Kavanagh, C. Howley, C. Tracey, E. Morrin, A. McDaid, A. Clarke, J.O. O'Neill, E. Joyce, M. O'Connell, N. G. Mahon   +15 more
wiley   +1 more source

Three-Dimensional Imaging of a Central Venous Dialysis Catheter Related Infected Thrombus

Case Reports in Nephrology, 2015
Three-dimensional (3D) echocardiography is becoming widely available and with novel applications. We report an interesting case of a 68-year-old lady with a central venous thrombosis coincident with both a dialysis catheter infection and a recent ...
Diana Yuan Yng Chiu, Darren Green, Philip A. Kalra, Nik Abidin   +3 more
doaj   +1 more source

Left ventricular diastolic dysfunction worsens prognosis in patients with heart failure due to dilated cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1183-1193, April 2025.
Abstract Aims The prognostic significance of left ventricular (LV) diastolic dysfunction (LVDD) severity in patients with dilated cardiomyopathy (DCM) remains uncertain. This study aimed to evaluate the association of LVDD severity and elevated left atrial pressure (eLAP) with patient outcomes in stable, non‐acutely decompensated patients with DCM ...
Mateusz Winiarczyk, Ewa Dziewięcka, Sylwia Wiśniowska‐Śmiałek, Agnieszka Stępień, Katarzyna Graczyk, Agata Leśniak‐Sobelga, Marta Hlawaty, Jakub Woźniak, Maryia Savitskaya, Katarzyna Holcman, Magdalena Kostkiewicz, Piotr Podolec, Paweł Rubiś   +12 more
wiley   +1 more source

The Clinical Application of Three-Dimensional Speckle Tracking Echocardiography and Two-Dimensional Echocardiography for Left Ventricular and Right Ventricular Assessment in Patients With Septic Cardiomyopathy. [PDF]

Korean Circ J, 2023
Cho EJ.
europepmc   +1 more source

Deep pyramid local attention neural network for cardiac structure segmentation in two-dimensional echocardiography

Medical Image Anal., 2020
Fei Liu, Kun Wang, Dan Liu, Xin Yang, Jie Tian   +4 more
semanticscholar   +1 more source

Metabolic abnormalities and reprogramming in cats with naturally occurring hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1256-1270, April 2025.
Abstract Background and aims The heart is a metabolic organ rich in mitochondria. The failing heart reprograms to utilize different energy substrates, which increase its oxygen consumption. These adaptive changes contribute to increased oxidative stress.
Qinghong Li, Max Homilius, Erin Achilles, Laura K. Massey, Victoria Convey, Åsa Ohlsson, Ingrid Ljungvall, Jens Häggström, Brittany Vester Boler, Pascal Steiner, Sharlene Day, Calum A. MacRae, Mark A. Oyama   +12 more
wiley   +1 more source

Case report: Imaging features of aorta-right atrial tunnel in a dog using two-dimensional echocardiography and computed tomography. [PDF]

Front Vet Sci, 2023
Kim G, Ji Y, Jeong HG, Lee T, Lee K, Yoon H.   +5 more
europepmc   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant, Matthias Schmitt, Anna B. Reid, Clifford J. Garratt, William G. Newman, Aneil Malhotra, Rhys Beynon, Masliza Mahmod, Betty Raman, Robert M. Cooper, Dana Dawson, Thomas Green, Sanjay K. Prasad, Anvesha Singh, Susanna Dodd, Hugh Watkins, Stefan Neubauer, Christopher A. Miller   +17 more
wiley   +1 more source

TC-SegNet: robust deep learning network for fully automatic two-chamber segmentation of two-dimensional echocardiography. [PDF]

Multimed Tools Appl, 2023
Lal S.
europepmc   +1 more source